I attended the Annual General Meeting of EKF Diagnostics (EKF) today via Zoom. This was one of the better organised electronic format AGMs I have attended. To quote from the company’s web site: “EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests. EKF also manufactures and distributes products associated with COVID-19 pandemic”. The latter has enabled the company to generate very high revenue growth recently ...
This morning I attended the virtual AGM of EKF Diagnostics (EKF), a medical products manufacturer mainly for diagnostic applications. There were about 12 attendees via a Zoom conference call and it worked quite well. Attendees were asked to register and submit questions in advance, although there was time to ask impromptu questions in the meeting also which were invited at the end.
Voting was done on a poll so the results of that were displayed first. The meeting was chaired by CEO ...
I attended the above at Cannaccord yesterday, the company is part of the healthcare “buy and build” specialist David Evans “stable of companies”, following on from his successes of Axis Shield, BBI International.
Market Cap = £80M
2014 PE = 26.3!
PEG = 0.50
Price to Sales = 2
The following members of the board were present:
Chairman - David Evans
CEO Julian Baines
Finance Director – Richard Evans
Non Exec - Dr Kevin Wilson
Company Secretary - Paul Foulger
Non Exec – Adam Reynolds
There were about four shareholders present, ...